The following is a summary of “Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study,” published in the February ...

France: In a recent pilot study, researchers are investigating the efficacy of phenolization as a treatment for sinus tracts ...

The use of combined oral contraceptives may delay the onset of hidradenitis suppurativa among women and may improve disease severity.

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...

A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...

Fact checked by Nick Blackmer It all started back in the spring of 2018 with a painful bump in my armpit. Confused, scared, ...

Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...

When it comes to managing hidradenitis suppurativa (HS) in special patient populations, new guidelines rate the existing evidence as “strong” for the following clinical scenarios: The ...

Psoriasis and hidradenitis suppurativa are both skin diseases that can impact cardiovascular health. Heart disease is the leading cause of death in America, so it's important to have a yearly skin ...

Managing hidradenitis suppurativa (HS) poses an array of challenges. This chronic inflammatory skin condition causes multiple symptoms, including painful abscesses in skin folds that ooze pus and ...